ChIMES feasibility study
Active, not recruiting
Who can enter
Children, and parents when the child is under 8 years old, being treated for cancer
Age: 0-18 years
Goal
Goal
The goal of this study is to find out whether it is practically feasible in daily care to use an oral score list (the so-called ChIMES) that is completed by a child or parent when there is a risk of a sore mouth (oral mucositis) as a result of chemo- and/or radiotherapy.
Background
Background
Oral mucositis is a common side effect of chemo- and/or radiotherapy. This can lead to problems with eating, drinking, talking, and swallowing, increased risk of infections due to the damaged mucous membranes, postponement of chemotherapy, and it can have an effect on the development of the teeth. In order to identify mucositis, we want to use an existing oral score list, the so called ChIMES (Children’s International Mucositis Evaluation Scale). We will check whether the ChIMES is easy to understand and use, and whether it is suitable and useful. Children, parents and paediatric (oncology) nurses will be asked about their experiences by means of an interview or questionnaire.
This study is now closed for inclusion.
Last reviewed
Last reviewed
March 20, 2026
Study details
- Study details
Official title
The feasibility of the ChIMES in children treated for cancer according to children, parents & nurses, a pilot studyCancer type
All types of cancer (Máxima broad)Maximum number of patients
20 children and or parentsStart date
April 15, 2022Status
Closed for inclusionLocal principal investigator
Prof. dr. W.J.E. TissingSponsor
Princess Máxima Center for pediatric oncologyApproval
For this study an accredited medical research ethics committee waived the need for official approval according to the Medical Research Involving Human Subjects Act (WMO). For more information: CCMO.
The above information is intended as a brief summary only and may not reflect the most up-to-date information. For full details and the current status of a protocol, physicians can contact the Princess Máxima Center directly.